• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亨廷顿病患者脑脊液中凝血酶原、载脂蛋白 A-IV 和触珠蛋白增加。

Increased prothrombin, apolipoprotein A-IV, and haptoglobin in the cerebrospinal fluid of patients with Huntington's disease.

机构信息

Department of Neurology, Chang Gung Memorial Hospital, Chang-Gung University College of Medicine, Taipei, Taiwan, People's Republic of China.

出版信息

PLoS One. 2011 Jan 31;6(1):e15809. doi: 10.1371/journal.pone.0015809.

DOI:10.1371/journal.pone.0015809
PMID:21297956
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3031520/
Abstract

Huntington's disease (HD) is a progressive neurodegenerative disease caused by an unstable CAG trinucleotide repeat expansion. The need for biomarkers of onset and progression in HD is imperative, since currently reliable outcome measures are lacking. We used two-dimensional electrophoresis and mass spectrometry to analyze the proteome profiles in cerebrospinal fluid (CSF) of 6 pairs of HD patients and controls. Prothrombin, apolipoprotein A-IV (Apo A-IV) and haptoglobin were elevated in CSF of the HD patients in comparison with the controls. We used western blot as a semi-quantified measurement for prothrombin and Apo A-IV, as well as enzyme linked immunosorbent assay (ELISA) for measurement of haptoglobin, in 9 HD patients and 9 controls. The albumin quotient (Qalb), a marker of blood-brain barrier (BBB) function, was not different between the HD patients and the controls. The ratios of CSF prothrombin/albumin (prothrombin/Alb) and Apo A-IV/albumin (Apo A-IV/Alb), and haptoglobin level were significantly elevated in HD. The ratio of CSF prothrombin/Alb significantly correlated with the disease severity assessed by Unified Huntington's Disease Rating Scale (UHDRS). The results implicate that increased CSF prothrombin, Apo A-IV, and haptoglobin may be involved in pathogenesis of HD and may serve as potential biomarkers for HD.

摘要

亨廷顿病(HD)是一种由不稳定的 CAG 三核苷酸重复扩展引起的进行性神经退行性疾病。在 HD 中,需要有起始和进展的生物标志物,因为目前缺乏可靠的结果测量方法。我们使用二维电泳和质谱分析法分析了 6 对 HD 患者和对照组的脑脊液(CSF)中的蛋白质组谱。与对照组相比,HD 患者的 CSF 中凝血酶原、载脂蛋白 A-IV(Apo A-IV)和触珠蛋白升高。我们使用 Western blot 作为凝血酶原和 Apo A-IV 的半定量测量方法,以及酶联免疫吸附测定(ELISA)来测量触珠蛋白,在 9 名 HD 患者和 9 名对照组中进行了测量。白蛋白商(Qalb)是血脑屏障(BBB)功能的标志物,在 HD 患者和对照组之间没有差异。CSF 凝血酶原/白蛋白(凝血酶原/Alb)和 Apo A-IV/白蛋白(Apo A-IV/Alb)的比值以及触珠蛋白水平在 HD 中显著升高。CSF 凝血酶原/Alb 比值与使用统一亨廷顿病评定量表(UHDRS)评估的疾病严重程度显著相关。这些结果表明,CSF 中凝血酶原、Apo A-IV 和触珠蛋白的增加可能与 HD 的发病机制有关,并可能作为 HD 的潜在生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35cd/3031520/1f4251efd262/pone.0015809.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35cd/3031520/ec21d4ba21e2/pone.0015809.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35cd/3031520/c75a6238e046/pone.0015809.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35cd/3031520/e1ac6579d051/pone.0015809.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35cd/3031520/b007bd722f97/pone.0015809.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35cd/3031520/1f4251efd262/pone.0015809.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35cd/3031520/ec21d4ba21e2/pone.0015809.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35cd/3031520/c75a6238e046/pone.0015809.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35cd/3031520/e1ac6579d051/pone.0015809.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35cd/3031520/b007bd722f97/pone.0015809.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35cd/3031520/1f4251efd262/pone.0015809.g005.jpg

相似文献

1
Increased prothrombin, apolipoprotein A-IV, and haptoglobin in the cerebrospinal fluid of patients with Huntington's disease.亨廷顿病患者脑脊液中凝血酶原、载脂蛋白 A-IV 和触珠蛋白增加。
PLoS One. 2011 Jan 31;6(1):e15809. doi: 10.1371/journal.pone.0015809.
2
Cerebrospinal fluid total tau concentration predicts clinical phenotype in Huntington's disease.脑脊液总tau蛋白浓度可预测亨廷顿舞蹈病的临床表型。
J Neurochem. 2016 Oct;139(1):22-5. doi: 10.1111/jnc.13719. Epub 2016 Sep 20.
3
Evaluation of Apo A IV and Haptoglobin as Potential CSF Markers in Patients with Guillain-Barre´ Syndrome: A Cross-Sectional Study.评估载脂蛋白 A-IV 和触珠蛋白作为格林-巴利综合征患者潜在的脑脊液标志物:一项横断面研究。
Neurol India. 2024 May 1;72(3):567-571. doi: 10.4103/neuroindia.NI_1914_20. Epub 2024 Jun 30.
4
Cerebrospinal fluid endo-lysosomal proteins as potential biomarkers for Huntington's disease.脑脊髓液内溶酶体蛋白作为亨廷顿病的潜在生物标志物。
PLoS One. 2020 Aug 17;15(8):e0233820. doi: 10.1371/journal.pone.0233820. eCollection 2020.
5
Neuropeptide Y (NPY) in cerebrospinal fluid from patients with Huntington's Disease: increased NPY levels and differential degradation of the NPY1-30 fragment.亨廷顿舞蹈症患者脑脊液中的神经肽Y(NPY):NPY水平升高及NPY1-30片段的差异降解
J Neurochem. 2016 Jun;137(5):820-37. doi: 10.1111/jnc.13624.
6
Comparative proteomics analysis of cerebrospinal fluid of patients with Guillain-Barré syndrome.格林-巴利综合征患者脑脊液的比较蛋白质组学分析
Cell Mol Neurobiol. 2008 Aug;28(5):737-44. doi: 10.1007/s10571-007-9257-7. Epub 2008 Mar 15.
7
Proteomic identification of potential protein markers in cerebrospinal fluid of GBS patients.吉兰-巴雷综合征(GBS)患者脑脊液中潜在蛋白质标志物的蛋白质组学鉴定
Eur J Neurol. 2007 May;14(5):563-8. doi: 10.1111/j.1468-1331.2007.01761.x.
8
Cerebrospinal fluid glial fibrillary acidic protein, in contrast to amyloid beta protein, is associated with disease symptoms in Huntington's disease.与β淀粉样蛋白不同,脑脊液中的胶质纤维酸性蛋白与亨廷顿舞蹈症的疾病症状相关。
J Neurol Sci. 2024 Apr 15;459:122979. doi: 10.1016/j.jns.2024.122979. Epub 2024 Mar 30.
9
Downregulation of Apolipoprotein-E and Apolipoprotein-J in Moyamoya Disease-A Proteome Analysis of Cerebrospinal Fluid.烟雾病中载脂蛋白E和载脂蛋白J的下调——脑脊液的蛋白质组分析
J Stroke Cerebrovasc Dis. 2017 Dec;26(12):2981-2987. doi: 10.1016/j.jstrokecerebrovasdis.2017.07.028. Epub 2017 Aug 23.
10
Clinical and genetic characteristics in patients with Huntington's disease from China.中国亨廷顿病患者的临床和遗传特征
Neurol Res. 2016 Oct;38(10):916-20. doi: 10.1080/01616412.2016.1214555. Epub 2016 Jul 29.

引用本文的文献

1
Identification and validation of a tear fluid-derived protein biomarker signature in patients with amyotrophic lateral sclerosis.肌萎缩侧索硬化症患者泪液衍生蛋白生物标志物特征的鉴定与验证
Acta Neuropathol Commun. 2025 Sep 2;13(1):187. doi: 10.1186/s40478-025-02109-6.
2
Serum Proteomic Changes in Pet Rabbits with Subclinical and Clinical Encephalitozoonosis in Thailand.泰国亚临床和临床脑胞内原虫病宠物兔的血清蛋白质组学变化
Animals (Basel). 2025 Jul 3;15(13):1962. doi: 10.3390/ani15131962.
3
A Pilot Proteomic Analysis of Huntington's Disease by Functional Capacity.

本文引用的文献

1
Elevated haptoglobin level of cerebrospinal fluid in Guillain-Barré syndrome revealed by proteomics analysis.蛋白质组学分析揭示格林-巴利综合征患者脑脊液触珠蛋白水平升高。
Proteomics Clin Appl. 2007 May;1(5):467-75. doi: 10.1002/prca.200600949. Epub 2007 Apr 19.
2
Targeting glial cells to elucidate the pathogenesis of Huntington's disease.针对神经胶质细胞阐明亨廷顿病的发病机制。
Mol Neurobiol. 2010 Jun;41(2-3):248-55. doi: 10.1007/s12035-009-8097-5. Epub 2010 Jan 28.
3
Neuroprotective role of haptoglobin after intracerebral hemorrhage.
基于功能能力的亨廷顿舞蹈病蛋白质组学初步分析
Brain Sci. 2025 Jan 16;15(1):76. doi: 10.3390/brainsci15010076.
4
Role of Thrombosis in Neurodegenerative Diseases: An Intricate Mechanism of Neurovascular Complications.血栓形成在神经退行性疾病中的作用:神经血管并发症的复杂机制
Mol Neurobiol. 2025 Apr;62(4):4802-4836. doi: 10.1007/s12035-024-04589-4. Epub 2024 Nov 1.
5
Diagnostic Potential of Alternations of Bile Acid Profiles in the Plasma of Patients with Huntington's Disease.亨廷顿舞蹈症患者血浆胆汁酸谱变化的诊断潜力
Metabolites. 2024 Jul 20;14(7):394. doi: 10.3390/metabo14070394.
6
Deregulated Transcriptome as a Platform for Adrenal Huntington's Disease-Related Pathology.去调控转录组作为肾上腺亨廷顿病相关病变的一个平台。
Int J Mol Sci. 2024 Feb 11;25(4):2176. doi: 10.3390/ijms25042176.
7
Microglia and complement mediate early corticostriatal synapse loss and cognitive dysfunction in Huntington's disease.小胶质细胞和补体介导亨廷顿病早期皮质纹状体突触丢失和认知功能障碍。
Nat Med. 2023 Nov;29(11):2866-2884. doi: 10.1038/s41591-023-02566-3. Epub 2023 Oct 9.
8
Ganglioside-focused Glycan Array Reveals Abnormal Anti-GD1b Auto-antibody in Plasma of Preclinical Huntington's Disease.神经节苷脂糖簇芯片揭示了临床前亨廷顿病患者血浆中异常的抗-GD1b 自身抗体。
Mol Neurobiol. 2023 Jul;60(7):3873-3882. doi: 10.1007/s12035-023-03307-w. Epub 2023 Mar 28.
9
Alternations of Lipoprotein Profiles in the Plasma as Biomarkers of Huntington's Disease.血浆脂蛋白谱的改变可作为亨廷顿病的生物标志物。
Cells. 2023 Jan 20;12(3):385. doi: 10.3390/cells12030385.
10
Cerebrospinal fluid biomarkers for assessing Huntington disease onset and severity.用于评估亨廷顿病发病和严重程度的脑脊液生物标志物。
Brain Commun. 2022 Nov 25;4(6):fcac309. doi: 10.1093/braincomms/fcac309. eCollection 2022.
血红素结合蛋白在脑出血后的神经保护作用。
J Neurosci. 2009 Dec 16;29(50):15819-27. doi: 10.1523/JNEUROSCI.3776-09.2009.
4
Prothrombin kringle-2-induced oxidative stress contributes to the death of cortical neurons in vivo and in vitro: role of microglial NADPH oxidase.凝血酶原kringle-2诱导的氧化应激在体内和体外均导致皮质神经元死亡:小胶质细胞NADPH氧化酶的作用。
J Neuroimmunol. 2009 Sep 29;214(1-2):83-92. doi: 10.1016/j.jneuroim.2009.07.005. Epub 2009 Aug 5.
5
Proteome analysis of haptoglobin in cerebrospinal fluid of neuromyelitis optica.视神经脊髓炎患者脑脊液中触珠蛋白的蛋白质组学分析。
Mol Biol Rep. 2010 Mar;37(3):1619-25. doi: 10.1007/s11033-009-9574-7. Epub 2009 May 15.
6
Levels of the light subunit of neurofilament triplet protein in cerebrospinal fluid in Huntington's disease.亨廷顿病患者脑脊液中神经丝三联蛋白轻链亚基水平
Parkinsonism Relat Disord. 2009 Mar;15(3):245-8. doi: 10.1016/j.parkreldis.2008.05.012. Epub 2008 Dec 4.
7
Brain-specific proteins decline in the cerebrospinal fluid of humans with Huntington disease.在患有亨廷顿舞蹈症的人类的脑脊液中,脑特异性蛋白质含量会下降。
Mol Cell Proteomics. 2009 Mar;8(3):451-66. doi: 10.1074/mcp.M800231-MCP200. Epub 2008 Nov 4.
8
Prothrombin/thrombin and the thrombin receptors PAR-1 and PAR-4 in the brain: localization, expression and participation in neurodegenerative diseases.大脑中的凝血酶原/凝血酶以及凝血酶受体PAR-1和PAR-4:定位、表达及在神经退行性疾病中的作用
Thromb Haemost. 2008 Oct;100(4):576-81.
9
A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease.一种在亨廷顿舞蹈症临床发病前即可检测到的新型免疫激活致病途径。
J Exp Med. 2008 Aug 4;205(8):1869-77. doi: 10.1084/jem.20080178. Epub 2008 Jul 14.
10
Pathophysiology of Huntington's disease: from huntingtin functions to potential treatments.亨廷顿舞蹈症的病理生理学:从亨廷顿蛋白的功能到潜在治疗方法
Curr Opin Neurol. 2008 Aug;21(4):497-503. doi: 10.1097/WCO.0b013e328304b692.